Hiv Infection clinical trials

Explore recruiting hiv infection clinical trials.

Recruiting hiv infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hiv Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Therapeutic vaccination: Phase I / II clinical study on patients randomized blinded to the experimental vaccine or placebo regimen. we want to evaluate the safety and the immunogenicity of a vaccine that includes a first administration of the ChAdOx1.tHIVconsvX product and a second one with MVA.tHIVconsvX in HIV-1 positive adults treated early and able to control the infection for a long time.

Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A clinical study of MK-4646 in people with HIV (MK-4646-003)

Romania

Human Pharmacology (Phase I)- Other EU CTIS Study details

A double blinded, phase II, placebo controlled, single centre randomized clinical trial to evaluate Metformin compared with placebo for reversal of accelerated biological aging in persons living with HIV 50 years or older and with suppressed virologic replication.

Spain

Phase I and Phase II (Integrated)- Bioequivalence Study EU CTIS Study details

A Phase 3 Open-label Rollover Clinical Study of Doravirine/Islatravir (DOR/ISL) Once daily for the Treatment of HIV-1 Infection in Participants Who Previously Received DOR/ISL in a Phase 2 or Phase 3 DOR/ISL Clinical Study

Italy, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Using lymph nOde fine needle aspiration to assess the effeCt of pnEumococcal vAcciNe platform, Age and HIV infection on Germinal cEntre formation (OCEAN-AGE)

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of Budigalimab and/or ABBV-382 in People Living with HIV on Stable Antiretroviral Therapy Undergoing Analytical Treatment Interruption.

Germany, Denmark, Italy, France, Poland, Belgium +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Hiv Infection trials by city

Hiv Infection in Toronto Hiv Infection in Vancouver Hiv Infection in Montreal Hiv Infection in Calgary Hiv Infection in Edmonton Hiv Infection in Ottawa Hiv Infection in Winnipeg Hiv Infection in Quebec City Hiv Infection in Hamilton Hiv Infection in Kitchener Hiv Infection in London Hiv Infection in Halifax Hiv Infection in New York Hiv Infection in Los Angeles Hiv Infection in Chicago Hiv Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease